Business Context and Reporting Period
Company: GAXOS.AI INC. (Ticker: GXAI)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2025
Business Overview: GAXOS.AI is a technology company developing AI applications for gaming (Gaxos Gaming, Gaxos Labs) and health (Gaxos Health, RNK Health). The company operates as a single segment and is classified as a smaller reporting company and an emerging growth company. As of March 31, 2025, the company reincorporated from Delaware to Nevada.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Revenues | $23,732 | $19 |
| Operating Expenses | $1,415,427 | $1,043,858 |
| Loss from Operations | $(1,391,695) | $(1,043,839) |
| Net Loss | $(1,232,062) | $(912,145) |
| Net Loss Attributable to Common Shareholders | $(1,191,800) | $(912,145) |
| Diluted EPS | $(0.17) | $(0.91) |
| Cash and Cash Equivalents | $2,571,340 | $3,312,277 |
| Short-Term Investments | $12,116,298 | $2,167,419 |
| Total Assets | $16,103,555 | $17,024,536 |
| Working Capital | $14,666,345 | $16,427,618 |
| Net Cash Used in Operating Activities | $(1,297,485) | $(1,099,417) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased significantly from $19 in Q1 2024 to $23,732 in Q1 2025. The majority ($22,552) was derived from non-clinical administrative services provided by the RNK Health subsidiary.
- Expense Increase: Total operating expenses rose 35.6% to $1.42 million. General and Administrative (G&A) expenses increased by $332,909, driven primarily by a $250,000 increase in executive bonuses and a $142,295 increase in marketing fees for RNK Health. R&D expenses increased 21.2% to $220,989.
- Investment Activity: The company significantly increased its short-term investment portfolio, purchasing $12.17 million in corporate bonds during the quarter, compared to $2.1 million in Q1 2024. This resulted in a net cash outflow of $10.5 million from investing activities.
- Intangible Assets: Intangible assets increased from $125,000 to $853,033 following the acquisition of software and technology for $500,000 in cash and 200,000 shares of common stock valued at $248,000.
Outlook, Risks, and Management Commentary
- Liquidity: Management states that existing working capital ($14.7 million) and cash on hand are sufficient to meet operating needs for the next 12 months. The company expects to continue generating operating losses due to corporate overhead, R&D, and public company costs.
- Strategic Initiatives:
- Gaxos Labs: Launched in September 2024, offering generative AI services to game developers.
- RNK Health: A 70% owned subsidiary providing non-clinical administrative support for telehealth services in partnership with a third-party medical management company.
- Risks:
- Regulatory: RNK Health's operations depend on a Medical Partner subject to evolving state laws regarding telehealth and medication management. Changes in regulations could materially adversely affect revenue.
- Capital Needs: Future success depends on obtaining additional financing to sustain operations and execute long-term plans.
- Market Risk: The company holds significant short-term investments subject to market fluctuations (unrealized loss of $69,040 recorded in Q1 2025).
- Unusual Items: The company issued 200,000 shares of common stock to acquire intangible assets (software) in February 2025. Additionally, the company recorded a realized gain on short-term investments of $11,445.
Investor Verification Checklist
- Revenue Sustainability: Verify the recurring nature of the $22,552 in revenue from RNK Health administrative services and the stability of the partnership with the Medical Partner.
- Cash Burn Rate: Confirm the company's ability to fund operations for 12 months given the net cash burn of ~$1.3 million in Q1 2025 and the lack of financing activities in the quarter.
- Investment Portfolio: Review the composition and credit quality of the $12.1 million short-term investment portfolio (corporate bonds) and assess exposure to interest rate risk.
- Executive Compensation: Note the $250,000 increase in executive bonuses included in G&A expenses and its impact on future cash flow projections.
- Regulatory Compliance: Monitor state-level regulatory changes affecting the telehealth business model of the RNK Health subsidiary.